Evoke Pharma, Inc. provided earnings guidance for 2024. For the period, the company projects net revenue of approximately $14 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.475 USD | +1.06% | +3.78% | -54.77% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.77% | 4.03M | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+16.34% | 239B | |
+6.68% | 204B | |
-9.08% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- EVOK Stock
- News Evoke Pharma, Inc.
- Evoke Pharma, Inc. Provides Earnings Guidance for 2024